Molecular Diagnostics Market
Updated Date: 06 July 2026   |   Report Code: 5150
sales@towardshealthcare.com +1 804-441-9344
Download Sample Order Now

Molecular Diagnostics Market Revenue and Analysis (2026-2035)

Projections indicate that, molecular diagnostics industry is projected to rise from USD 17.1 billion in 2025 to USD 28.66 billion by 2035, reflecting a CAGR of 5.3% over the next decade. The molecular diagnostics is growing rapidly, driven by advancements in genetic testing, infectious disease detection, and personalized medicine. It enables precise, fast, and early diagnosis using DNA/RNA analysis, improving patient outcomes. Demand is rising with innovations in PCR, NGS, and point-of-care tests.

Last Updated : 06 July 2026 Category: Diagnostics Insight Code: 5150 Format: PDF / PPT / Excel

Content

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Molecular Diagnostics Market Assessment

  • Overview
  • Global Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Instruments and Systems
    • Reagents and Kits
    • Software
    • Other Products
  • Global Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Polymerase chain reaction (PCR) 
      • Multiplex PCR
      • Others
    • In Situ Hybridization (ISH)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Chips and Microarrays
    • Mass Spectrometry
    • Sequencing
    • Transcription Mediated Amplification (TMA)
    • Other Technologies
  • Global Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Oncology 
      • Breast Cancer
      • Prostate Cancer
      • Colorectal Cancer
      • Cervical Cancer
      • Kidney Cancer
      • Liver Cancer
      • Blood Cancer
      • Lung Cancer
      • Other Cancers
    • Pharmacogenomics 
      • Infectious Diseases
      • Methicillin-resistant Staphylococcus Aureus (MRSA)
      • Clostridium Difficile
      • Vancomycin-resistant Enterococci (VRE)
      • Carbapenem-resistant Bacteria
      • Flu
      • Respiratory Syncytial Virus (RSV)
      • Candida
      • Tuberculosis and Drug-resistant TBA
      • Meningitis
      • Gastrointestinal Panel Testing
      • Chlamydia
      • Gonorrhea
      • HIV
      • Hepatitis C
      • Hepatitis B
      • Other Infectious Diseases
    • Genetic Testing 
      • Newborn Screening
      • Predictive and Presymptomatic Testing
      • Other Genetic Testing
    • Neurological Disease
    • Cardiovascular Disease
    • Microbiology
    • Others
  • Global Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Test Location (2021 – 2033)
    • Point of Care
    • Self-test or OTC
    • Central Laboratories
  • Global Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • South America

North America Molecular Diagnostics Market Assessment

  • Overview
  • North America Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Instruments and Systems
    • Reagents and Kits
    • Software
    • Other Products
  • North America Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Polymerase chain reaction (PCR) 
      • Multiplex PCR
      • Others
    • In Situ Hybridization (ISH)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Chips and Microarrays
    • Mass Spectrometry
    • Sequencing
    • Transcription Mediated Amplification (TMA)
    • Other Technologies
  • North America Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Oncology 
      • Breast Cancer
      • Prostate Cancer
      • Colorectal Cancer
      • Cervical Cancer
      • Kidney Cancer
      • Liver Cancer
      • Blood Cancer
      • Lung Cancer
      • Other Cancers
    • Pharmacogenomics 
      • Infectious Diseases
      • Methicillin-resistant Staphylococcus Aureus (MRSA)
      • Clostridium Difficile
      • Vancomycin-resistant Enterococci (VRE)
      • Carbapenem-resistant Bacteria
      • Flu
      • Respiratory Syncytial Virus (RSV)
      • Candida
      • Tuberculosis and Drug-resistant TBA
      • Meningitis
      • Gastrointestinal Panel Testing
      • Chlamydia
      • Gonorrhea
      • HIV
      • Hepatitis C
      • Hepatitis B
      • Other Infectious Diseases
    • Genetic Testing 
      • Newborn Screening
      • Predictive and Presymptomatic Testing
      • Other Genetic Testing
    • Neurological Disease
    • Cardiovascular Disease
    • Microbiology
    • Others
  • North America Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Test Location (2021 – 2033)
    • Point of Care
    • Self-test or OTC
    • Central Laboratories

Europe Molecular Diagnostics Market Assessment

  • Overview
  • Europe Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Instruments and Systems
    • Reagents and Kits
    • Software
    • Other Products
  • Europe Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Polymerase chain reaction (PCR) 
      • Multiplex PCR
      • Others
    • In Situ Hybridization (ISH)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Chips and Microarrays
    • Mass Spectrometry
    • Sequencing
    • Transcription Mediated Amplification (TMA)
    • Other Technologies
  • Europe Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Oncology 
      • Breast Cancer
      • Prostate Cancer
      • Colorectal Cancer
      • Cervical Cancer
      • Kidney Cancer
      • Liver Cancer
      • Blood Cancer
      • Lung Cancer
      • Other Cancers
    • Pharmacogenomics 
      • Infectious Diseases
      • Methicillin-resistant Staphylococcus Aureus (MRSA)
      • Clostridium Difficile
      • Vancomycin-resistant Enterococci (VRE)
      • Carbapenem-resistant Bacteria
      • Flu
      • Respiratory Syncytial Virus (RSV)
      • Candida
      • Tuberculosis and Drug-resistant TBA
      • Meningitis
      • Gastrointestinal Panel Testing
      • Chlamydia
      • Gonorrhea
      • HIV
      • Hepatitis C
      • Hepatitis B
      • Other Infectious Diseases
    • Genetic Testing 
      • Newborn Screening
      • Predictive and Presymptomatic Testing
      • Other Genetic Testing
    • Neurological Disease
    • Cardiovascular Disease
    • Microbiology
    • Others
  • Europe Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Test Location (2021 – 2033)
    • Point of Care
    • Self-test or OTC
    • Central Laboratories

Asia Pacific Molecular Diagnostics Market Assessment

  • Overview
  • Asia Pacific Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Instruments and Systems
    • Reagents and Kits
    • Software
    • Other Products
  • Asia Pacific Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Polymerase chain reaction (PCR) 
      • Multiplex PCR
      • Others
    • In Situ Hybridization (ISH)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Chips and Microarrays
    • Mass Spectrometry
    • Sequencing
    • Transcription Mediated Amplification (TMA)
    • Other Technologies
  • Asia Pacific Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Oncology 
      • Breast Cancer
      • Prostate Cancer
      • Colorectal Cancer
      • Cervical Cancer
      • Kidney Cancer
      • Liver Cancer
      • Blood Cancer
      • Lung Cancer
      • Other Cancers
    • Pharmacogenomics 
      • Infectious Diseases
      • Methicillin-resistant Staphylococcus Aureus (MRSA)
      • Clostridium Difficile
      • Vancomycin-resistant Enterococci (VRE)
      • Carbapenem-resistant Bacteria
      • Flu
      • Respiratory Syncytial Virus (RSV)
      • Candida
      • Tuberculosis and Drug-resistant TBA
      • Meningitis
      • Gastrointestinal Panel Testing
      • Chlamydia
      • Gonorrhea
      • HIV
      • Hepatitis C
      • Hepatitis B
      • Other Infectious Diseases
    • Genetic Testing 
      • Newborn Screening
      • Predictive and Presymptomatic Testing
      • Other Genetic Testing
    • Neurological Disease
    • Cardiovascular Disease
    • Microbiology
    • Others
  • Asia Pacific Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Test Location (2021 – 2033)
    • Point of Care
    • Self-test or OTC
    • Central Laboratories

Middle East and Africa Molecular Diagnostics Market Assessment

  • Overview
  • Middle East and Africa Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Instruments and Systems
    • Reagents and Kits
    • Software
    • Other Products
  • Middle East and Africa Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Polymerase chain reaction (PCR) 
      • Multiplex PCR
      • Others
    • In Situ Hybridization (ISH)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Chips and Microarrays
    • Mass Spectrometry
    • Sequencing
    • Transcription Mediated Amplification (TMA)
    • Other Technologies
  • Middle East and Africa Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Oncology 
      • Breast Cancer
      • Prostate Cancer
      • Colorectal Cancer
      • Cervical Cancer
      • Kidney Cancer
      • Liver Cancer
      • Blood Cancer
      • Lung Cancer
      • Other Cancers
    • Pharmacogenomics 
      • Infectious Diseases
      • Methicillin-resistant Staphylococcus Aureus (MRSA)
      • Clostridium Difficile
      • Vancomycin-resistant Enterococci (VRE)
      • Carbapenem-resistant Bacteria
      • Flu
      • Respiratory Syncytial Virus (RSV)
      • Candida
      • Tuberculosis and Drug-resistant TBA
      • Meningitis
      • Gastrointestinal Panel Testing
      • Chlamydia
      • Gonorrhea
      • HIV
      • Hepatitis C
      • Hepatitis B
      • Other Infectious Diseases
    • Genetic Testing 
      • Newborn Screening
      • Predictive and Presymptomatic Testing
      • Other Genetic Testing
    • Neurological Disease
    • Cardiovascular Disease
    • Microbiology
    • Others
  • Middle East and Africa Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Test Location (2021 – 2033)
    • Point of Care
    • Self-test or OTC
    • Central Laboratories

South America Molecular Diagnostics Market Assessment

  • Overview
  • South America Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Instruments and Systems
    • Reagents and Kits
    • Software
    • Other Products
  • South America Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Polymerase chain reaction (PCR) 
      • Multiplex PCR
      • Others
    • In Situ Hybridization (ISH)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Chips and Microarrays
    • Mass Spectrometry
    • Sequencing
    • Transcription Mediated Amplification (TMA)
    • Other Technologies
  • South America Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Oncology 
      • Breast Cancer
      • Prostate Cancer
      • Colorectal Cancer
      • Cervical Cancer
      • Kidney Cancer
      • Liver Cancer
      • Blood Cancer
      • Lung Cancer
      • Other Cancers
    • Pharmacogenomics 
      • Infectious Diseases
      • Methicillin-resistant Staphylococcus Aureus (MRSA)
      • Clostridium Difficile
      • Vancomycin-resistant Enterococci (VRE)
      • Carbapenem-resistant Bacteria
      • Flu
      • Respiratory Syncytial Virus (RSV)
      • Candida
      • Tuberculosis and Drug-resistant TBA
      • Meningitis
      • Gastrointestinal Panel Testing
      • Chlamydia
      • Gonorrhea
      • HIV
      • Hepatitis C
      • Hepatitis B
      • Other Infectious Diseases
    • Genetic Testing 
      • Newborn Screening
      • Predictive and Presymptomatic Testing
      • Other Genetic Testing
    • Neurological Disease
    • Cardiovascular Disease
    • Microbiology
    • Others
  • South America Molecular Diagnostics Market Size Value (US$) and Volume (Billion Tons), by Test Location (2021 – 2033)
    • Point of Care
    • Self-test or OTC
    • Central Laboratories

Company Profiles

  • BD
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Abbott
  • Agilent Technologies, Inc.
  • Danaher
  • Hologic Inc. (Gen Probe)
  • Illumina, Inc.
  • Grifols, S.A.
  • QIAGEN
  • F. Hoffmann-La Roche, Ltd.
  • Siemens Healthineers AG
  • Sysmex Corporation

Conclusion & Recommendations

FAQ's

Answer : The molecular diagnostics market is on a steady upward track. From USD 18.01 billion in 2026, it is projected to reach USD 28.66 billion by 2035, growing at a 5.3% CAGR

Answer : Speed, precision, and accessibility are leading the way. Point-of-care testing is the fastest-growing segment, while PCR, NAATs, next-generation sequencing, and liquid biopsies are becoming mainstream

Answer : North America continues to dominate due to strong healthcare infrastructure and major industry players.
Any Questions

Meet the Team

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar